Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burlein

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Scientific Reports|May 17, 2024
Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factorFrederic Brösecke, Anja Pfau, Theresa Ermer, et al.
Protein Expression and Purification|January 12, 2010
Purification of untagged HIV-1 reverse transcriptase by affinity chromatographyMeiqing Lu, Winnie Ngo, Ye Mei, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2010
Epsilon substituted lysinol derivatives as HIV-1 protease inhibitorsKristen L G Jones, M Katharine Holloway, Hua-Poo Su, et al.
Nature|June 6, 1991
New use of BCG for recombinant vaccinesC K Stover, V F de la Cruz, T R Fuerst, et al.
Journal of Medicinal Chemistry|September 16, 2011
Design, synthesis, and X-ray crystallographic analysis of a novel class of HIV-1 protease inhibitorsAshit K Ganguly, Sesha S Alluri, Danielle Caroccia, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2023
Discovery of arylsulfonamides as a novel class of allosteric integrase inhibitors with antiviral activityCheng Wang, Gregory C Adam, Christine Burlein, et al.
The Journal of Infectious Diseases|February 11, 2000
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coliS Langermann, R Möllby, J E Burlein, et al.
Nature Communications|May 25, 2021
Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymeraseRobert P Hayes, Mee Ra Heo, Mark Mason, et al.
Journal of Medical Genetics|February 4, 2022
Dominant negative mutation in oxalate transporter <i>SLC26A6</i> associated with enteric hyperoxaluria and nephrolithiasisNicolas Cornière, R Brent Thomson, Stéphanie Thauvin, et al.
Vaccine|March 6, 1999
Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccineR Edelman, K Palmer, K G Russ, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Scientific Reports|May 17, 2024
Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factorFrederic Brösecke, Anja Pfau, Theresa Ermer, et al.
Protein Expression and Purification|January 12, 2010
Purification of untagged HIV-1 reverse transcriptase by affinity chromatographyMeiqing Lu, Winnie Ngo, Ye Mei, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2010
Epsilon substituted lysinol derivatives as HIV-1 protease inhibitorsKristen L G Jones, M Katharine Holloway, Hua-Poo Su, et al.
Nature|June 6, 1991
New use of BCG for recombinant vaccinesC K Stover, V F de la Cruz, T R Fuerst, et al.
Journal of Medicinal Chemistry|September 16, 2011
Design, synthesis, and X-ray crystallographic analysis of a novel class of HIV-1 protease inhibitorsAshit K Ganguly, Sesha S Alluri, Danielle Caroccia, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2023
Discovery of arylsulfonamides as a novel class of allosteric integrase inhibitors with antiviral activityCheng Wang, Gregory C Adam, Christine Burlein, et al.
The Journal of Infectious Diseases|February 11, 2000
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coliS Langermann, R Möllby, J E Burlein, et al.
Nature Communications|May 25, 2021
Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymeraseRobert P Hayes, Mee Ra Heo, Mark Mason, et al.
Journal of Medical Genetics|February 4, 2022
Dominant negative mutation in oxalate transporter <i>SLC26A6</i> associated with enteric hyperoxaluria and nephrolithiasisNicolas Cornière, R Brent Thomson, Stéphanie Thauvin, et al.
Vaccine|March 6, 1999
Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccineR Edelman, K Palmer, K G Russ, et al.
Pageof 8